Ocugen to present modifier gene therapy platform at Oppenheimer biotech summit

Reuters2026/07/31 11:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ocugen will present its modifier gene therapy platform at the Oppenheimer Biotech in the Berkshires Summit on Aug. 4, 2026, in Lenox, Massachusetts.
The company will also take part in the Canaccord Annual Growth Conference on Aug. 11, 2026, in Boston.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310702PRIMZONEFULLFEED9800977) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Ocugen to present modifier gene therapy platform at Oppenheimer biotech summit

You may also like

Crypto prices